HOME > TESTING > TESTS RELATED TO PATHOLOGIES

Tests related to pathologies

Pathologies

Code

Name

Target

Pharm. Ref.
Biology
PDF

Epilepsy

P-001

Fast sodium channel inhibition

Sodium channels

Tetrodotoxin

Action Potential genesis and propagation

Hungtington’s Disease

P-001

Fast sodium channel inhibition

Sodium channels

Tetrodotoxin

Action Potential genesis and propagation

Hyperactivity and Attention Deficit Disorders

P-001

Fast sodium channel inhibition

Sodium channels

Tetrodotoxin

Action Potential genesis and propagation

Multiple Sclerosis

P-001

Fast sodium channel inhibition

Sodium channels

Tetrodotoxin

Action Potential genesis and propagation

Neuropathic Pain

P-001

Fast sodium channel inhibition

Sodium channels

Tetrodotoxin

Action Potential genesis and propagation

Pain

P-001

Fast sodium channel inhibition

Sodium channels

Tetrodotoxin

Action Potential genesis and propagation

Amyotrophic Lateral Sclerosis

P-002

AMPA-mediated synaptic transmission

AMPA/Kainate receptors

NBQX

Glutamatergic synaptic transmission

Epilepsy

P-002

AMPA-mediated synaptic transmission

AMPA/Kainate receptors

NBQX

Glutamatergic synaptic transmission

Stroke

P-002

AMPA-mediated synaptic transmission

AMPA/Kainate receptors

NBQX

Glutamatergic synaptic transmission

Alzheimer’s Disease

P-003

NMDA receptors competitive antagonist

NMDA receptors

D-AP5

Long-Term Potentiation

Hungtington’s Disease

P-003

NMDA receptors competitive antagonist

NMDA receptors

D-AP5

Long-Term Potentiation

Parkinson’s Disease

P-003

NMDA receptors competitive antagonist

NMDA receptors

D-AP5

Long-Term Potentiation

Schizophrenia

P-003

NMDA receptors competitive antagonist

NMDA receptors

D-AP5

Long-Term Potentiation

Anxiety

P-004

GABA-A receptors - Network Excitability

GABA-A receptors

Bicuculline

Epileptiform activity

Epilepsy

P-004

GABA-A receptors - Network Excitability

GABA-A receptors

Bicuculline

Epileptiform activity

Sleep Disorders

P-004

GABA-A receptors - Network Excitability

GABA-A receptors

Bicuculline

Epileptiform activity

Anxiety

P-005

Neurosteroids / GABA-A receptors

GABA-A receptors

Ganaxolone

Allosteric modulation of GABA-A

Epilepsy

P-005

Neurosteroids / GABA-A receptors

GABA-A receptors

Ganaxolone

Allosteric modulation of GABA-A

Sleep Disorders

P-005

Neurosteroids / GABA-A receptors

GABA-A receptors

Ganaxolone

Allosteric modulation of GABA-A

Anxiety

P-006

Inhibition of phasic GABA-A receptors

Phasic GABA-A receptors

Gabazin (SR-95531)

GABA-A receptor-mediated fast synaptic transmission

Epilepsy

P-006

Inhibition of phasic GABA-A receptors

Phasic GABA-A receptors

Gabazin (SR-95531)

GABA-A receptor-mediated fast synaptic transmission

Sleep Disorders

P-006

Inhibition of phasic GABA-A receptors

Phasic GABA-A receptors

Gabazin (SR-95531)

GABA-A receptor-mediated fast synaptic transmission

Addiction

P-007

DHPG - induced LTD

mGluR1 & mGluR5 receptors

DHPG

LTD induced by mGluR1/mGluR5 activation

Anxiety

P-007

DHPG - induced LTD

mGluR1 & mGluR5 receptors

DHPG

LTD induced by mGluR1/mGluR5 activation

Epilepsy

P-007

DHPG - induced LTD

mGluR1 & mGluR5 receptors

DHPG

LTD induced by mGluR1/mGluR5 activation

Neurodegeneration

P-007

DHPG - induced LTD

mGluR1 & mGluR5 receptors

DHPG

LTD induced by mGluR1/mGluR5 activation

Pain

P-007

DHPG - induced LTD

mGluR1 & mGluR5 receptors

DHPG

LTD induced by mGluR1/mGluR5 activation

Stroke

P-007

DHPG - induced LTD

mGluR1 & mGluR5 receptors

DHPG

LTD induced by mGluR1/mGluR5 activation

Cognitive Disorders

P-008

AMPA/kainate receptors-mediated excitotoxicity

AMPA/kainate receptors

Kainate

Excitotoxicity

Epilepsy

P-008

AMPA/kainate receptors-mediated excitotoxicity

AMPA/kainate receptors

Kainate

Excitotoxicity

Pain

P-008

AMPA/kainate receptors-mediated excitotoxicity

AMPA/kainate receptors

Kainate

Excitotoxicity

Stroke

P-008

AMPA/kainate receptors-mediated excitotoxicity

AMPA/kainate receptors

kainate

Excitotoxicity

Cognitive Disorders

P-009

L-type calcium channels / Synaptic Transmission

L-type VDCC

Nifedipine

Modulation of synaptic transmission by VDCC

Depression

P-009

L-type calcium channels / Synaptic Transmission

L-type VDCC

Nifedipine

Modulation of synaptic transmission by VDCC

Epilepsy

P-009

L-type calcium channels / Synaptic Transmission

L-type VDCC

Nifedipine

Modulation of synaptic transmission by VDCC

Stroke

P-009

L-type calcium channels / Synaptic Transmission

L-type VDCC

Nifedipine

Modulation of synaptic transmission by VDCC

Alzheimer’s Disease

P-010

Cholinergic transmission - Alzheimer's Disease

Acetylcholinesterase

Physostigmine (Eserine)

Cholinergic modulation of glutamate neurotransmission

Cognitive Disorders

P-010

Cholinergic transmission - Alzheimer's Disease

Acetylcholinesterase

Physostigmine (Eserine)

Cholinergic modulation of glutamate neurotransmission

Dementia

P-010

Cholinergic transmission - Alzheimer's disease

Acetylcholinesterase

Physostigmine (Eserine)

Cholinergic modulation of glutamate neurotransmission

Hyperactivity and Attention Deficit Disorders

P-010

Cholinergic transmission - Alzheimer's Disease

Acetylcholinesterase

Physostigmine (Eserine)

Cholinergic modulation of glutamate neurotransmission

Alzheimer’s Disease

P-011

NMDA & nicotinic receptors / Alzheimer's & Parkinson's Diseases

NMDA & nicotinic receptors

Memantine

Long-Term Potentiation / Memory

Dementia

P-011

NMDA & nicotinic receptors / Alzheimer's & Parkinson's Diseases

NMDA & nicotinic receptors

Memantine

Long-Term Potentiation / Memory

Parkinson’s Disease

P-011

NMDA & nicotinic receptors / Alzheimer's & Parkinson's Diseases

NMDA & nicotinic receptors

Memantine

Long-Term Potentiation / Memory

Alzheimer’s Disease

P-012

H3 histamine receptor-dependent depression in Dentate Gyrus

H3 histamine receptor

R-alpha-methylhistamine

Pre-synaptic H3 receptor

Anxiety

P-012

H3 histamine receptor-dependent depression in Dentate Gyrus

H3 histamine receptor

R-alpha-methylhistamine

Pre-synaptic H3 receptor

Cognitive Disorders

P-012

H3 histamine receptor-dependent depression in Dentate Gyrus

H3 histamine receptor

R-alpha-methylhistamine

Pre-synaptic H3 receptor

Epilepsy

P-012

H3 histamine receptor-dependent depression in Dentate Gyrus

H3 histamine receptor

R-alpha-methylhistamine

Pre-synaptic H3 receptor

Hyperactivity and Attention Deficit Disorders

P-012

H3 histamine receptor-dependent depression in Dentate Gyrus

H3 histamine receptor

R-alpha-methylhistamine

Pre-synaptic H3 receptor

Obesity

P-012

H3 histamine receptor-dependent depression in Dentate Gyrus

H3 histamine receptor

R-alpha-methylhistamine

Pre-synaptic H3 receptor

Parkinson’s Disease

P-012

H3 histamine receptor-dependent depression in Dentate Gyrus

H3 histamine receptor

H3 histamine receptorR-alpha-methylhistamine

Pre-synaptic H3 receptor

Schizophrenia

P-012

H3 histamine receptor-dependent depression in Dentate Gyrus

H3 histamine receptor

R-alpha-methylhistamine

Pre-synaptic H3 receptor

Sleep Disorders

P-012

H3 histamine receptor-dependent depression in Dentate Gyrus

H3 histamine receptor

R-alpha-methylhistamine

Pre-synaptic H3 receptor

Anxiety

P-013

Histamine receptors mediated increase of CA1 pyramidal neurons firing

H1 and H2 histamine receptors

Histamine

CA1 pyramidal neurons spontaneous activity

Cognitive Disorders

P-013

Histamine receptors mediated increase of CA1 pyramidal neurons firing

H1 and H2 histamine receptors

Histamine

CA1 pyramidal neurons spontaneous activity

Pain

P-013

Histamine receptors mediated increase of CA1 pyramidal neurons firing

H1 and H2 histamine receptors

Histamine

CA1 pyramidal neurons spontaneous activity

Sleep Disorders

P-013

Histamine receptors mediated increase of CA1 pyramidal neurons firing

H1 and H2 histamine receptors

Histamine

CA1 pyramidal neurons spontaneous activity

Addiction

P-014

mGluR2-mediated depression of synaptic transmission at MPP synapses

mGluR2 receptors

DCG-IV

Pre-synaptic mGluR2 receptors

Anxiety

P-014

mGluR2-mediated depression of synaptic transmission at MPP synapses

mGluR2 receptors

DCG-IV

Pre-synaptic mGluR2 receptors

Obsessive-Compulsive Disorders

P-014

mGluR2-mediated depression of synaptic transmission at MPP synapses

mGluR2 receptors

DCG-IV

Pre-synaptic mGluR2 receptors

Cognitive Disorders

P-015

Dopamine-induced increase of synaptic transmission and plasticity

D1/D5 dopamine receptors

SCH23390

Dopaminergic modulation of synaptic transmission

Parkinson’s Disease

P-015

Dopamine-induced increase of synaptic transmission and plasticity

D1/D5 dopamine receptors

SCH23390

Dopaminergic modulation of synaptic transmission

Epilepsy

P-016

Model of 4-AP-induced Epilepsy

K+ channel

Phenytoin / Carbamazepine

In vitro Epilepsy model

Epilepsy

P-017

Model of low-magnesium-induced Epilepsy

NMDA receptor

Phenytoin / Carbamazepine

In vitro Epilepsy model

Epilepsy

P-018

Model of bicuculline-induced Epilepsy

GABA-A receptor

Somatostatin

In vitro model of Epilepsy

Epilepsy

P-019

Model of cholinergic-induced epilepsy

GABA-A / M1muscarinic receptors

diazepam

In vitro Epilepsy model

 

© & CREDITS
Domaine de St Hilaire • 595, rue Pierre Berthier • CS 30531 • 13593 AIX EN PROVENCE Cedex 03 • FRANCE
tel : + 33 (0)442 991 220 • fax : +33 (0)442 643 409 • mail : contact@neuroservice.comwww.neuroservice.com